C92.00
Conditions
Interventions
Group 1: Intervention group (receives a VR headset with suitable applications promoting movement and concentration for free independent use during standard care).
Group 2: Control group (receives only
Sponsors
UKSH Campus Lübeck, Klinik für Hämatologie/Onkologie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Written consent after clarification - Ability to follow instructions in German or English - Inpatient treatment for one of the following therapies: High-dose chemotherapy for acute leukemia or autologous or allogeneic stem cell transplantation
Exclusion criteria
Exclusion criteria: - Serious cardiac diseases (e.g. heart failure NYHA III, myocardial infarction III - Severe global pulmonary insufficiency - Severe neurological, amnestic or cognitive impairments - Lack of technical skills
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Global Health Status score (EORTC QLQ-C30) at discharge and two weeks post-discharge compared to the score at hospital admission. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total score in the DEMMI test at admission, discharge, and two weeks post-discharge Total score in the DASS test at admission, discharge, and two weeks post-discharge Total score in the D2-R test at admission, discharge, and two weeks post-discharge Total score in the Trail Making Test B at admission, discharge, and two weeks post-discharge Handgrip strength at admission, discharge, and two weeks post-discharge Change in each parameter over time (compared to baseline at admission) | — |
Countries
Germany
Contacts
Public ContactDr. med. Friederike Wortmann
UKSH Campus Lübeck, Klinik für Hämatologie/Onkologie
Outcome results
None listed